ECDC, DG SANTE and EFSA, supported by a consortium composed of Epiconcept and Integrated Quality Laboratory Services (IQLS), jointly carried out a country visit to Kosovo* from 9 to 13 October 2023, which is part of ECDC’s accession support activities to contribute to the advancement of a One Health approach against antimicrobial resistance (AMR) in the Western Balkans.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11-17 May 2024 and includes updates on invasive meningococcal disease, an overview of respiratory virus epidemiology in the EU/EEA, cholera and measles.
This document outlines the objectives and main elements of the ECDC framework for prevention of communicable diseases and related special health issues.
For 2022, 28 European Union/European Economic Area (EU/EEA) countries reported data on Crimean-Congo haemorrhagic fever (CCHF) and two countries reported a total of four cases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 May 2024 and includes updates on cholera and western equine encephalitis.
This report contains genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 August 2023 until 31 January 2024.
Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.